latest news

QACV Consulting Chief Compliance Officer featured in QUASAR magazine
Archiving with Integrity: Turning ‘Storage’ into a Compliance Asset

Quasar #175, RQA Publication I May 2026

October
2026

QACV Consulting Stacked logo

As a QMO, QACV Consulting is working toward becoming ISO 9001 certified in early 2027, with the goal of strengthening our internal processes, promoting continuous improvement, managing risk, and consistently meeting the needs and expectations of our clients and other interested parties.

As part of this effort, QACV Consulting will continue to review and enhance its quality processes, conduct internal audits, and monitor the effectiveness of our Quality Management System (QMS). This initiative reflects QACV’s ongoing commitment to quality, consistency, accountability, continuous improvement, and client satisfaction.

Through this journey, QACV Consulting is further strengthening its quality culture and establishing a solid foundation for consistent, reliable, and client-focused services. Our commitment to continuous improvement remains at the heart of everything we do.

September
2026

QACV Consulting Stacked logo

QACV Consulting is honored to have provided specialized AI and Data Integrity training to the FDA’s Office of Scientific Investigations (OSI). On September 2 and 9, 2026, Bob Wherry, QACV’s Vice President of AI Compliance, delivered two training sessions exploring the evolving landscape of artificial intelligence within the regulated life sciences industry. The sessions addressed industry and regulatory challenges, real-world case studies, and key compliance considerations associated with the development, implementation, and use of AI technologies. As AI continues to transform the life sciences industry, QACV remains committed to supporting organizations in navigating emerging regulatory expectations, strengthening data integrity, and implementing AI technologies responsibly and effectively.

If you are interested in learning more about the training provided to the FDA or what you may need to ensure compliance in the AI landscape, please contact QACV at contact@qacvconsulting.com.

Training

MAY
2026

QACV Consulting Stacked logo

We are proud to share that our Chief Compliance Officer, Erika Reategui, has been featured in the May 2026 edition of Quasar magazine, published by the Research Quality Association (RQA) publication, QUASAR #175 with the article: “Archiving with Integrity: Turning ‘Storage’ into a Compliance Asset”

Her article, explores the critical role that archiving plays in maintaining data integrity, regulatory compliance, and inspection readiness across regulated industries. Too often, archiving is viewed simply as a storage function. In reality, effective archiving strategies are essential for protecting records, supporting business continuity, ensuring accessibility, and demonstrating compliance with evolving regulatory expectations.

Through this publication, Erika highlights how organizations can transform their archiving programs into strategic compliance assets that support quality, efficiency, and long-term operational success.

We are honored to contribute to the industry’s ongoing dialogue around quality and compliance and congratulate Erika on this achievement.

10-12
FEBRUARY 2026

QACV Consulting Stacked logo

QACV Consulting successfully conducted its Annual Quality Meeting on February 10–12 at our Texas Medical Center office in Houston, bringing our team together to align on strategic quality priorities, enhance internal processes, and reinforce our commitment to excellence as a compliance-driven organization.

The meeting provided a valuable opportunity to strengthen collaboration across teams while supporting our continued growth. During the week, we were also pleased to present QACV’s capabilities and key compliance focus areas at the Wednesday Lunch & Learn session, fostering meaningful dialogue and engaging discussions with attendees.

qacv annual meeting photos

JANUARY
2026

SeerPharma logo

SeerPharma clients now gain direct access to QACV’s experienced Quality and GxP professionals based in the U.S.
This strategic partnership rests on two guiding principles that strengthen the synergy between both organizations:

  • Global Synergy: QACV Consulting, in turn, can leverage SeerPharma’s expertise for support in the Asia-Pacific region—ensuring compliance across FDA, EMA, PMDA, and other global frameworks.
  • Shared Mission: Jointly committed to “Advancing Quality and GMP best practices” across regions and accelerating client success.

SeerPharma has a team of consultants that provide advice, training, software solutions from Master Control, and contract labor resources to pharmaceutical, medical device and life science companies in the Asia-Pacific region, on matters of Quality Assurance and GMP compliance. Serving clients in the Asia-Pacific region for over 35 years from their offices in Australia and Singapore, and are also able to provide assistance in Europe through their affiliate in the UK.

SeerPharm photo collage

Through this partnership, we aim to join forces to support SeerPharma mision, Advancing Quality and GMP best practices in the APAC region for the Pharmaceutical and Medical Device industries.

We are confident that this alliance marks the beginning of a successful journey and we look forward to the impact we will create together.

august
2025

QACV Consulting Stacked logo

We are thrilled to join a thriving and rapidly growing life sciences community in the Houston area. We are excited to announce the August 1st opening of our new office location in the Texas Medical Center Innovation Building.

We will host events and complimentary GxP training sessions. We will also participate in the Texas Life Science Forum held at the Rice University campus on November 11th, 2025. This move marks a strategic step toward building meaningful local partnerships and future business opportunities allowing us to engage directly with Houston-based researchers, startups, and thought leaders developing the next generation of therapeutics.

QACV Consulting welcomes our established and prospective clients to come visit us at our new location at 2540 Holcombe Blvd, Suite X, Houston, TX 77021.

Please contact us for more information at contact@qacvconsulting.com.

21-24
july 2025

Chris Wubbolt, CEO, Principal Consultant of QACV Consulting, delivered a well-received presentation titled: “GxPs – Differences and Similarities between GLP, GCP, and GMPs.”

In this engaging 60-minute session, Chris offered a comparative overview of the Good Laboratory Practices (GLP), Good Clinical Practices (GCP), and Good Manufacturing Practices (GMP), addressing their regulatory frameworks, scopes, and operational impact. The presentation served as both a foundational training and a strategic discussion, with a focus on the critical role of Quality Assurance within each GxP.

  • Understanding the distinct goals of each GxP: safety and integrity of data (GLP), protection of human subjects (GCP), and product quality and consistency (GMP).
  • Exploring the similarities across the regulations, such as documentation, change control, and data integrity.
  • Discussing overlapping responsibilities and organizational structures within quality systems.
  • Emphasizing the importance of tailoring QA oversight to the unique demands of each regulated area.


Key takeaways included:

We are grateful for the opportunity to contribute to the broader QA community and look forward to continued collaboration with SQA regional chapters and quality professionals nationwide.

Looking ahead, QACV Consulting will continue building on this momentum, delivering workshops and strategic advisory services focused on computerized systems validation and GxP compliance. Contact us to receive a copy of his presentation.